PGI14 COST-UTILITY OF A MODALITY OF “C” VIRUS HEPATITIS TREATMENT IN PATIENTS THAT DO NOT RESPOND TO INTERFERON PLUS RIBAVIRIN IN MEXICO
Abstract
Authors
A Nevarez-Sida P Constantino-Casas F Garcia-Contreras
A Nevarez-Sida P Constantino-Casas F Garcia-Contreras
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now